Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001707315-24-000001
Filing Date
2024-02-26
Accepted
2024-02-23 20:04:45
Documents
1
Effectiveness Date
2024-02-26
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10067
  Complete submission text file 0001707315-24-000001.txt   11168
Mailing Address 180 NORTH UNIVERSITY AVENUE SUITE 820 PROVO UT 84601
Business Address 180 NORTH UNIVERSITY AVENUE SUITE 820 PROVO UT 84601 801-367-9298
Thunder Biotech, Inc. (Filer) CIK: 0001707315 (see all company filings)

EIN.: 813738317 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-506016 | Film No.: 24673262